Nova (NMR) AI Stock Analysis

Nova

(Frankfurt:NMR)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

High ProfitabilityNova’s high gross, EBIT, and net margins indicate strong earnings power and differentiated economics in semiconductor metrology. This profitability can support continued investment in product development, customer support, and market expansion while providing resilience across the industry cycle.

Negative Factors

Higher LeverageDebt has increased materially from 2024 levels, reducing financial flexibility even though current equity backing remains meaningful. Higher leverage could constrain capital allocation and make Nova less adaptable if semiconductor conditions weaken or investment needs rise.

Nova (NMR) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 9.93B
Dividend Yield: ―
Average Volume (3M): 64
Price to Earnings (P/E): 36.0
Beta (1Y): 0.48
Revenue Growth: 8.29%
EPS Growth: 0.90%
Country: Germany
Employees: 1,612
Sector: Technology
Sector Strength: 61
Industry: Semiconductors

Nova Business Overview & Revenue Model

Company Description

Nova Ltd. is a global innovator specializing in the design, development, production, and sale of sophisticated process control systems vital for semiconductor manufacturing. Its extensive reach covers key regions such as Israel, Taiwan, the United St...

Nova Earnings Call Summary

Earnings Call Date:May 13, 2026(Q1-2026)|% Change Since:-29.70%|Next Earnings Date:Nov 04, 2026

Earnings Call SentimentPositive

The call conveyed strong operational and financial momentum: record revenue, record profitability, market-share gains (400 bps), broad-based product and service strength, and upward guidance for Q2. Management addressed risks but presented clear mitigation steps (capacity expansion, supplier management, R&D investment). The lowlights—supplier cost pressure, competition (notably in China and XPS/material metrology), a slightly elevated tax rate, and some uncertainty on process-control dynamics—are notable but relatively limited compared with the positive financial outcomes and strategic progress.

Positive Updates

Record Quarterly Revenue

Revenue of $235.3 million in Q1 2026, a 6% increase quarter-over-quarter and a 10% increase year-over-year, exceeding the high end of guidance.

Negative Updates

Supplier and Cost Pressure

Management noted some supply-chain pressure and supplier cost inflation tied to higher chip prices and other factors; company is mitigating via supplier management and cost actions but cost pressure remains a risk.

Company Guidance

Nova guided second-quarter 2026 revenue of $245–$255 million, GAAP diluted EPS of $2.10–$2.24 and non‑GAAP diluted EPS of $2.34–$2.48; at the midpoint it expects GAAP gross margin ≈57% and non‑GAAP gross margin ≈59%, GAAP operating expenses of ≈$72 million (≈$66 million non‑GAAP), non‑GAAP financial income of ≈$16 million and an effective tax rate of ≈15%. For context, the guidance follows a record Q1 (revenue $235.3M, +6% QoQ / +10% YoY) with Q1 blended gross margins of 57.7% GAAP / 59.4% non‑GAAP, operating margins of 30% GAAP / 34% non‑GAAP, GAAP operating expenses $64.9M ($59.4M non‑GAAP) and Q1 EPS of $2.04 GAAP / $2.33 non‑GAAP.

Nova Risk Analysis

Nova disclosed 51 risk factors in its most recent earnings report. Nova reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks

1.If a United States person is treated as owning at least 10% of our shares, such holder may be subject to adverse U.S. federal income tax consequences.Q4, 2019

2.The Tax Cuts and Jobs Act of 2017 could adversely affect our business and financial condition.Q4, 2019

3.Political, economic and military instability in Israel may impede our ability to operate and harm our financial results.Q4, 2019

Nova Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

DE:NMR against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ASML	82Outperform	$602.71B	40.34	63.91%	0.59%	28.99%	52.09%
AMAT	73Outperform	$309.57B	33.43	40.44%	0.51%	7.77%	38.45%
KLAC	73Outperform	$205.75B	39.25	87.02%	0.53%	15.80%	25.58%
ONTO	70Outperform	$9.89B	75.21	6.50%	―	8.08%	-33.87%
CAMT	62Neutral	$5.45B	145.85	5.82%	―	7.94%	-72.56%
Sector *	61Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%

* Technology Sector Average

Performance Comparison

DE:NMR and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:NMR	Nova Ltd.	294.00	3.60	1.24%
AMAT	Applied Materials, Inc.	390.09	161.17	70.40%
ASML	Asml Holding N.V.	1565.90	541.11	52.80%
CAMT	Camtek	116.68	-0.78	-0.66%
KLAC	Kla Corporation	157.91	39.20	33.02%
ONTO	Onto Innovation	201.57	72.46	56.12%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Nova AI Stock Analysis